Naevoid Basal Cell Carcinoma Syndrome

Document Type : Letter to Editor

Authors

1 Associate Professor, Skin and Stem Cell Research Center, Tehran University of Medical Sciences, Tehran And Department of Dermatology, School of Medicine, Isfahan University School of Medical Sciences, Isfahan, Iran

2 Resident, Skin Diseases and Leishmaniasis Research Center, Department of Dermatology, School of Medicine And Student Research Committee, Isfahan University of Medical Sciences, Isfahan, Iran

3 Assistant Professor, Skin Disease and Leishmaniasis Research Center And Department of Dermatology, Isfahan University of Medical Sciences, Isfahan, Iran

Abstract

Nevoid basal cell carcinoma syndrome (NBCCS), also known as Gorlin syndrome, is a hereditary condition characterized by a wide range of developmental abnormalities and a predisposition to neoplasms. The estimated prevalence varies from 1/57,000 to 1/256,000, with a male-to-female ratio of 1:1. Main clinical manifestations include multiple basal cell carcinomas (BCCs), odontogenic keratocysts of the jaw, hyperkeratosis of palms and soles, skeletal abnormalities, intracranial ectopic calcifications, and facial dysmorphism (macrocephaly, cleft lip/palate and severe eye anomalies). This paper introduces three NBCCS patients and describes their symptoms. In our first case, two major (multiple BCCs in younger than 30 years of age, and palmar pits) and one minor (medulloblastoma) criteria were met, which were indicative of Gorlin syndrome. The second case had two major criteria (multiple BCCs in younger than 30 years of age and odontogenic keratocyst), which confirmed Gorlin syndrome. The third case had one major criterion (multiple BCCs) and two minor criteria (congenital skeletal anomaly and frontal bossing) which confirmed Gorlin syndrome. Early diagnosis and treatment is important in preventing long term squeals of this syndrome that include malignancy and oromaxillofacial deformation and destruction.

Keywords


  1. Lo ML. Nevoid basal cell carcinoma syndrome (Gorlin syndrome). Orphanet J Rare Dis 2008;
  2. : 32.
  3. Lo ML, Nocini PF, Savoia A, Consolo U, Procaccini M, Zelante L, et al. Nevoid basal cell carcinoma syndrome. Clinical findings in 37 Italian affected individuals. Clin Genet 1999; 55(1): 34-40.
  4. Manfredi M, Vescovi P, Bonanini M, Porter S. Nevoid basal cell carcinoma syndrome: a review of the literature. Int J Oral Maxillofac Surg 2004; 33(2): 117-24.
  5. Lo ML, Nocini P, Bucci P, Pannone G, Consolo U, Procaccini M. Early diagnosis of nevoid basal cell carcinoma syndrome. J Am Dent Assoc 1999; 130(5): 669-74.
  6. Gorlin RJ. Nevoid Basal cell carcinoma syndrome. Medicine 1977; 66: 97-113.